Evidence map›Paper›PMID 25373456›Full record

ArticleMolecular cancer2014

Copy-neutral loss of heterozygosity and chromosome gains and losses are frequent in gastrointestinal stromal tumors.

Nelson Lourenço, Zofia Hélias-Rodzewicz, Jean-Baptiste Bachet, Sabrina Brahimi-Adouane, Fabrice Jardin, Jeanne Tran van Nhieu, Frédérique Peschaud, Emmanuel Martin, Alain Beauchet, Frédéric Chibon and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Diploidy confers genomic instability inbioRxiv : the preprint server for biology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy.Journal of diabetes and metabolic disorders · 2018
    Review
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Nelson LourençoEA4340, Versailles University, Boulogne-Billancourt, France. nelourenco@wanadoo.fr.
Zofia Hélias-RodzewiczEA4340, Versailles University, Boulogne-Billancourt, France. zofia.helias@apr.aphp.fr.
Jean-Baptiste BachetEA4340, Versailles University, Boulogne-Billancourt, France. jean-baptiste.bachet@psl.aphp.fr.
Sabrina Brahimi-AdouaneEA4340, Versailles University, Boulogne-Billancourt, France. brasab@hotmail.fr.
Fabrice JardinCentre Henri Becquerel, INSERM U918, Université de Rouen, Rouen, France. fabrice.jardin@rouen.fnclcc.fr.
Jeanne Tran van NhieuDepartment of Pathology, Henri Mondor Hospital, APHP, Créteil, France. jeanne.tran-van-nhieu@hmn.aphp.fr.
Frédérique PeschaudEA4340, Versailles University, Boulogne-Billancourt, France. frederique.peschaud@apr.aphp.fr.
Emmanuel MartinIntegragen, Evry, France. Emmanuel.Martin@integragen.com.
Alain BeauchetEA4340, Versailles University, Boulogne-Billancourt, France. alain.beauchet@apr.aphp.fr.
Frédéric ChibonBergonié Institut, INSERM U916, Bordeaux, France. F.Chibon@bordeaux.unicancer.fr.
Jean-François EmileEA4340, Versailles University, Boulogne-Billancourt, France. jean-francois.emile@uvsq.fr.
Hôpital Ambroise-Paré · FRInstitut Bergonié · FRIntegraGen (France) · FRUniversité de Rouen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA KIT gain of function mutation is present in 70% of gastrointestinal stromal tumors (GISTs) and the wild-type (WT) allele is deleted in 5 to 15% of these cases. The WT KIT is probably deleted during GIST progression. We aimed to identify the mechanism of WT KIT loss and to determine whether other genes are involved or affected.

methodsWhole-genome SNP array analyses were performed in 22 GISTs with KIT exon 11 mutations, including 11 with WT loss, to investigate the mechanisms of WT allele deletion. CGH arrays and FISH were performed in some cases. Common genetic events were identified by SNP data analysis. The 9p21.3 locus was studied by multiplex quantification of genomic DNA.

resultsChromosome instability involving the whole chromosome/chromosome arm (whole C/CA) was detected in 21/22 cases. The GISTs segregated in two groups based on their chromosome number: polyGISTs had numerous whole C/CA gains (mean 23, range [9 to 43]/3.11 [1 to 5]), whereas biGISTs had fewer aberrations. Whole C/CA losses were also frequent and found in both groups. There were numerous copy-neutral losses of heterozygosity (cnLOH) of whole C/CA in both polyGIST (7/9) and biGIST (9/13) groups. cnLOH were frequent on 4q, 11p, 11q, 1p, 2q, 3p and 10, and never involved 12p, 12q, 20p, 20q or 19q. Other genetic alterations included segmental chromosome abnormalities, complete bi-allelic deletions (homozygous deletions) and, more rarely, amplifications. Nine of 11 GISTs with homozygous KIT exon 11 mutations had cnLOH of chromosome 4.

conclusionThe cnLOH of whole C/CA is a frequent genetic alteration in GISTs and is closely associated with homozygous mutations of KIT and WT allele deletion.

Indexed as

Chromosome DeletionLoss of HeterozygosityAdultAgedAged, 80 and overCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16Disease ProgressionFemaleGastrointestinal Stromal TumorsHumansIn Situ Hybridization, FluorescenceMaleMiddle AgedPolyploidyCyclin-Dependent Kinase Inhibitor p15Cyclin-Dependent Kinase Inhibitor p16

Identifiers

PMID25373456
PMCPMC4417285
OpenAlexW2144732169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.